Загрузка...
Clinical Options in Relapsed or Refractory Hodgkin Lymphoma: An Updated Review
Hodgkin lymphoma (HL) is a potentially curable lymphoma, and modern therapy is expected to successfully cure more than 80% of the patients. Second-line salvage high-dose chemotherapy and autologous stem cell transplantation (auto-SCT) have an established role in the management of refractory and rela...
Сохранить в:
| Опубликовано в: : | J Immunol Res |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Hindawi Publishing Corporation
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4695673/ https://ncbi.nlm.nih.gov/pubmed/26788526 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/968212 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|